146 related articles for article (PubMed ID: 6806643)
1. The effect of testosterone treatment on the ability of female rat liver S9 to activate aflatoxin B1 and 2-aminofluorene in the AMES/Salmonella system.
Chernesky P; Jayaraj A; Richardson A
Mutat Res; 1982 Mar; 103(3-6):267-73. PubMed ID: 6806643
[No Abstract] [Full Text] [Related]
2. Genetic dependence of hepatic microsome-mediated depression of aflatoxin B1 activation to mutagens in Ames Salmonella typhimurium TA-98 system.
Raina V; Gurtoo HL; Berrigan M; Paigen B
Biochem Biophys Res Commun; 1980 Jun; 94(3):737-43. PubMed ID: 6772179
[No Abstract] [Full Text] [Related]
3. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
Ishii K; Maeda K; Kamataki T; Kato R
Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of aflatoxin B1 mutagenesis: addition of glutathione and glutathione-S-transferase to the Salmonella mutagenicity assay.
Jorgensen KV; Clayton JW; Price RL
Environ Mutagen; 1987; 9(4):411-9. PubMed ID: 3107976
[TBL] [Abstract][Full Text] [Related]
5. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
Yourtee DM; Kirk-Yourtee CL
Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
[TBL] [Abstract][Full Text] [Related]
6. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
Uwaifo AO; Bababunmi EA
Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
[TBL] [Abstract][Full Text] [Related]
7. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems.
Beaune P; Lemestré-Cornet R; Kremers P; Albert A; Gielen J
Mutat Res; 1985 Jun; 156(3):139-46. PubMed ID: 3889631
[TBL] [Abstract][Full Text] [Related]
8. Cytosol is required for the modulation by dietary casein of the hepatic microsomal activation of aflatoxin B1 to mutagenic metabolites detectable in Salmonella.
Woodall GM; Dauterman WC; Hagler WM; DeMarini DM
Mutagenesis; 1999 Jul; 14(4):365-73. PubMed ID: 10390503
[TBL] [Abstract][Full Text] [Related]
9. Species-dependent effects of dietary lindane and/or zineb on the activation of aflatoxin B1 into mutagenic derivatives.
Decloitre F; Hamon G
Mutat Res; 1980 Nov; 79(3):185-92. PubMed ID: 6163982
[TBL] [Abstract][Full Text] [Related]
10. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
Jayaraj A; Hardwick JP; Diller TW; Richardson AG
J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
[TBL] [Abstract][Full Text] [Related]
11. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
Pavlov IuI; Khromov-Borisov NN
Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
San RH; Chan RI
Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
[TBL] [Abstract][Full Text] [Related]
13. The mutagenicity of 2-nitrofluoranthene and its in vitro hepatic metabolites.
Zielinska B; Harger WP; Arey J; Winer AM; Haas RA; Hanson CV
Mutat Res; 1987 Apr; 190(4):259-66. PubMed ID: 3550452
[No Abstract] [Full Text] [Related]
14. [Changes in the mutagenic effect of a medium containing aflatoxin B1 as a result of the yeast activity].
Borisenko AE; Mirskaia EE; Borisenko EG
Gig Sanit; 1990 Dec; (12):45-7. PubMed ID: 2128746
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of aflatoxin B1 by using the synergistic effect of hydrogen peroxide and gamma radiation.
Patel UD; Govindarajan P; Dave PJ
Appl Environ Microbiol; 1989 Feb; 55(2):465-7. PubMed ID: 2497710
[TBL] [Abstract][Full Text] [Related]
16. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1.
Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O
J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559
[TBL] [Abstract][Full Text] [Related]
17. The effect of substrates and inhibitors of monoamine oxidase on hepatic dimethylnitrosamine metabolism and mutagenicity.
Lake BG; Rowland IR; Harris RA; Collins MA; Phillips JC; Cottrell RC; Gangolli SD
Adv Exp Med Biol; 1981; 136 Pt B():1143-7. PubMed ID: 6283820
[No Abstract] [Full Text] [Related]
18. Lack of mutagenicity of diphenylhydantoin in in vitro short-term tests.
Léonard A; de Meester C; Fabry L; de Saint-Georges L; Dumont P
Mutat Res; 1984; 137(2-3):79-88. PubMed ID: 6433192
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
Bodine AB; Luer CA; Gangjee S
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
[TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of 3a,8a-dihydrofuro[2,3-b]benzofuran, a model of aflatoxin B1, for Salmonella typhimurium TA100.
Coles BF; Smith JR; Garner RC
Biochem Biophys Res Commun; 1977 Jun; 76(3):888-92. PubMed ID: 332158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
